Axsome Therapeutics (AXSM) Profit After Tax Growth (1y) (2016 - 2026)
Axsome Therapeutics (AXSM) Profit After Tax Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 0.26% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -107.76% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 101.22% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Axsome Therapeutics | 12.28 Bn | 11.98 Bn | 176.48 Mn | -8.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.63% |
| Dec 31, 2025 | 61.88% |
| Sep 30, 2025 | 26.89% |
| Jun 30, 2025 | 39.54% |
| Mar 31, 2025 | 13.08% |
| Dec 31, 2024 | 24.06% |
| Sep 30, 2024 | -3.86% |
| Jun 30, 2024 | -18.13% |
| Mar 31, 2024 | -509.35% |
| Dec 31, 2023 | -178.49% |
| Sep 30, 2023 | -38.77% |
| Jun 30, 2023 | -62.09% |
| Mar 31, 2023 | 71.69% |
| Dec 31, 2022 | 469.91% |
| Sep 30, 2022 | -28.50% |
| Jun 30, 2022 | -28.36% |
| Mar 31, 2022 | -35.45% |
| Dec 31, 2021 | -16.50% |
| Sep 30, 2021 | -52.16% |
| Jun 30, 2021 | -76.16% |